Rallybio (RLYB) announced that it received an equity milestone payment of $12.5M from Recursion Pharmaceuticals (RXRX). The milestone payment was ...

Detailed price information for Rallybio Corporaton (RLYB-Q) from The Globe and Mail including charting and trades.

Today, the value of this approach is widely recognised even by most pharmaceutical companies, a number of which – including Sanofi, Roche and Genentech, Bayer, and Merck KgaA – have partnered with ...

Self-Referential Large Models: Recursive Self-Enhancement in Code Generation ...

Recursion will also receive an additional $30 million upfront payment from Bayer to develop new treatments for chronic scar tissue, or fibrotic, diseases of the lung, kidneys and heart.

We recently published 12 Best Healthcare Stocks to Buy Under $30. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best healthcare stocks. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a ...

Venice: After a fourteen-year absence, McElwee returns to filmmaking with an affecting tribute to his son’s life that doubles ...

The most profound failures in history are not those that bet big and lost, but those that failed to bet at all. Incremental advances will never cure Alzheimer’s disease or reverse climate change. To ...

New research explores how prolonged AI interactions can, at least for some users, start to blur the lines between reality and fantasy. Simple interventions could prevent tragic outcomes.

Absci's AI-driven drug discovery platform, its potential, challenges, and strategic partnerships. Read here for an investment analysis of ABSI stock.

Artificial Intelligence is very much in the news these days, so I decided to do a critical analysis of one of works ...